Journal of Infection
Volume 57, Issue 2 , Pages 152-157 , August 2008

Acute hepatitis B in patients with or without underlying chronic HCV infection

  • E. Biliotti

      Affiliations

    • Department of Infectious and Tropical Diseases, University “La Sapienza” of Rome, Italy
    • ,
  • L.A. Kondili

      Affiliations

    • Dipartimento di Malattie Infettive, Parassitarie e Immunomediate, Istituto Superiore di Sanità, Roma
    • ,
  • C. Furlan

      Affiliations

    • Department of Infectious and Tropical Diseases, University “La Sapienza” of Rome, Italy
    • ,
  • G. Ferretti

      Affiliations

    • Department of Infectious and Tropical Diseases, Policlinico Umberto I, Rome, Italy
    • ,
  • S. Zacharia

      Affiliations

    • Department of Infectious and Tropical Diseases, University “La Sapienza” of Rome, Italy
    • ,
  • M. De Angelis

      Affiliations

    • Department of Infectious and Tropical Diseases, Policlinico Umberto I, Rome, Italy
    • ,
  • S. Guidi

      Affiliations

    • Department of Infectious and Tropical Diseases, University “La Sapienza” of Rome, Italy
    • ,
  • N. Gusman

      Affiliations

    • Department of Infectious and Tropical Diseases, University “La Sapienza” of Rome, Italy
    • ,
  • G. Taliani

      Affiliations

    • Department of Infectious and Tropical Diseases, University “La Sapienza” of Rome, Italy
    • Corresponding Author InformationCorresponding author. Dipartimento di Malattie Infettive e Tropicali, La Sapienza Università di Roma, Viale del Policlinico 155, 00161 Roma, Italy. Tel./fax: +39 06 49970491.

,Accepted 18 April 2008.

References 

  1. Bianco E, Stroffolini T, Spada E, Szklo A, Marzolini F, Ragni P, et al. Case fatality rate of acute viral hepatitis in Italy: 1995–2000. An update. Dig Liver Dis. 2003;35:404–408
  2. Liaw YF, Yeh CT, Tsai SL. Impact of acute hepatitis B virus superinfection on chronic hepatitis C virus infection. Am J Gastroenterol. 2000;95:2978–2980
  3. Sagnelli E, Coppola N, Messina V, Di Caprio D, Marrocco C, Marotta A, et al. HBV superinfection in hepatitis C virus chronic carriers, viral interaction and clinical course. Hepatology. 2002;36:1285–1291
  4. Coppola N, Marrocco C, Di Caprio D, Coviello G, Scolastico C, Filippini P, et al. Acute hepatitis B and C virus coinfection: a virological and clinical study of 3 cases. Clin Infect Dis. 2003;36:528–532
  5. Akuta N, Suzuki F, Kobayashi M, Tsubota A, Suzuki Y, Hosaka T, et al. Effect of acute self-limited hepatitis C virus (HCV) superinfection on hepatitis B virus (HBV) related cirrhosis. Virological features of HBV–HCV dual infection. Dig Dis Sci. 2004;49(2):281–288
  6. Sagnelli E, Coppola N, Marrocco C, Onofrio M, Sagnelli C, Coviello G, et al. Hepatitis C virus superinfection in hepatitis B virus chronic carriers: a reciprocal viral interaction and a variable clinical course. J Clin Virol. 2006;35:317–320
  7. Jardi R, Rodrigues F, Buti M, Costa X, Cotrina M, Galimany R, et al. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology. 2001;34:404–410
  8. Sagnelli E, Pasquale G, Coppola N, Scarano F, Marrocco C, Scolastico C, et al. Influence of chronic coinfection with hepatitis B and C virus on liver histology. Infection. 2004;32:144–148
  9. Raimondo G, Brunetto MR, Pontisso P, Smedile A, Maina AM, Saitta C, et al. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus coinfected patients. Hepatology. 2006;43:100–107
  10. Sagnelli E, Coppola N, Scolastico C, Filippini P, Santantonio T, Stroffolini T, et al. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C and delta viruses in patients with chronic hepatitis. Hepatology. 2000;32:1106–1110
  11. El-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology. 2002;36(5 Suppl. 1):S74–S83
  12. Shi J, Zhu L, Liu S, Xie WF. A meta-analysis of case–control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer. 2005;92:607–612
  13. Guido M, Rugge M, Colombari R, Cecchetto A, Scarpa A, Cadrobbi P. Prompt hepatitis C virus suppression following hepatitis B virus superinfection in chronic untreated hepatitis C. Ital J Gastroenterol Hepatol. 1998;30:414–417
  14. Wietzke P, Schott P, Braun F, Mihim S, Ramadori G. Clearance of HCV-RNA in a chronic hepatitis C virus infected patient during acute hepatitis B virus superinfection. Liver. 1999;19:348–353
  15. Krogsgaard K, Wantzin P, Matheiesen L, Ring-Larsen H, the Copenhagen Acute Hepatitis Programme . Chronic evolution of acute hepatitis B: the significance of simultaneous infections with hepatitis C and D. Scand J Gastroenterol. 1991;26:275–280
  16. Kondili LA, Brunetto MR, Maina AM, Argentini C, Chionne P, La Sorsa V, et al. Clinical and molecular characterisation of chronic hepatitis B in Albania: a country that is still highly endemic for HBV infection. J Med Virol. 2005;75:20–26
  17. Taliani G, Rapicetta M, Francisci D, Xiang J, Sarrecchia B, De Bac C, et al. Correlation of preS antigens and clinical status during chronic hepatitis B virus infection. Med Microbiol Immunol. 1991;180(5):239–248
  18. Taliani G, Celestino D, Badolato MC, Pennica A, Bozza A, Poliandri G, et al. Hepatitis C virus infection of salivary gland epithelial cells. Lack of evidence. J Hepatol. 1997;26(6):1200–1206
  19. Sroffolini T, Mele A, Tosti ME, Gallo G, Balocchini E, Ragni P, et al. The impact of hepatitis immunisation campaign on the incidence of and risk factors for hepatitis B in Italy. J Hepatol. 2000;33:980–985
  20. Fagan EA, Smith PM, Davison F, Williams R. Fulminant hepatitis B in successive female sexual partners of two anti-HBe-positive males. Lancet. 1986;2(8506):538–540
  21. Ozasa A, Tanaka Y, Orito E, Sugiyama M, Kang JH, Hige S, et al. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology. 2006;44:326–334
  22. Sato S, Suzuki K, Akahane Y, Akamatsu K, Akiyama K, Yunomura K, et al. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med. 1995;15(122):241–248
  23. Petrosillo N, Ippolito G, Solforosi L, Varaldo PE, Clementi M, Manzin A. Molecular epidemiology of an outbreak of fulminant hepatitis B. J Clin Microbiol. 2000;38:2975–2981
  24. Whalley SA, Murray JM, Brown D, Webster GJ, Emery VC, Dusheiko GM, et al. Kinetics of acute hepatitis B virus infection in humans. J Exp Med. 2001;193(7):847–853
  25. Webster GJM, Reignat S, Maini MK, Whalley SA, Ogg GS, King A, et al. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology. 2000;32:1117–1124
  26. Kondili L, Osman H, Mutimer D. The use of lamivudine for patients with acute hepatitis B (a series of cases). J Viral Hepat. 2004;11:427–431
  27. Schuttler CG, Fiedler N, Schmidt K, Repp R, Gerlich WH, Schaefer S. Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein. J Hepatol. 2000;37(6):855–862
  28. Shih CM, Lo SJ, Miyamura T, Chen SY, Lee YH. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol. 1993;67:5823–5832
  29. Liaw YF. Concurrent hepatitis B and C virus infection: is hepatitis C virus stronger?. J Gastroenterol Hepatol. 2001;216:597–598
  30. Liaw WF. Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology. 1995;22:1101–1108
  31. Lanotte P, Dubois F, Le Pogam S, Guerois C, Fimbel B, Bacq Y, et al. The kinetics of antibodies against hepatitis C virus may predict viral clearance in exposed hemophiliacs. J Infect Dis. 1998;178:556–559
  32. Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Kondili LA, Menniti-Ippolito F, et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology. 1997;26:1006–1011
  33. Maio G, D'Argenio P, Stroffolini T, Bozza A, Sacco L, Tosti ME, et al. Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town. J Hepatol. 2000;33:116–120
  34. Deterding K, Tegtmeyer B, Cornberg M, Hadem J, Potthoff A, Boker KH, et al. Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV. J Hepatol. 2006;45:770–778
  35. Sagnelli E, Coppola N, Pisaturo M, Pisapia R, Onofrio M, Sagnelli C, et al. Clinical and virological improvement of hepatitis B virus-related or hepatitis C virus-related chronic hepatitis with concomitant hepatitis A virus infection. Clin Infect Dis. 2006;42(11):1536–1543
  36. Gruener NH, Jung MC, Ulsenheimer A, Gerlach TJ, Diepolder HM, Schirren CA, et al. Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response. J Hepatol. 2002;37:866–869
  37. Chulanov VP, Shipulin GA, Schaefer S, Gerlich WH. Kinetics of HBV-DNA and HBsAg in acute hepatitis B patients with and without coinfection by other hepatitis viruses. J Med Virol. 2003;69:313–323
  38. Boni C, Amadei B, Urbani S, Fisicaro P, Zerbini A, Mori C, et al. Antiviral CD8 mediated responses in chronic HCV carriers with HBV superinfection. Hepatology. 2004;40:289–299
  39. NIH consensus statement on management of hepatitis C: 2002. NIH Consens State Sci Statements. 2002;19(3):1–46

PII: S0163-4453(08)00157-6

doi: 10.1016/j.jinf.2008.04.006

Journal of Infection
Volume 57, Issue 2 , Pages 152-157 , August 2008

Article Tools